Scientists at ETH Zurich have made a breakthrough towards designing an off-the-shelf treatment for immunotherapy against cancer. A synthetic protein …
Storyboard
Synthetic protein tweak could lead to universal cancer immunotherapy
Scientists have made a breakthrough towards an off-the-shelf treatment for immunotherapy against cancer. A synthetic protein tweak can allow immune cells from any donor to be given to any patient without the risk of a dangerous immune reaction.
MORE ON CANCER IMMUNOTHERAPIES
